Starlin Haydon-Greatting, MS, BSPharm, claims that pharmacist education has changed; by furthering education and credentials, a pharmacist's role in the healthcare world can extend far beyond what were once thought to be the traditional roles of the pharmacist. Pharmacists' involvement in programs such as the Medication Therapy Management, for example, can have a positive impact on health management in general.
Starlin Haydon-Greatting, MS, BSPharm, claims that pharmacist education has changed; by furthering education and credentials, a pharmacist’s role in the healthcare world can extend far beyond what were once thought to be the traditional roles of the pharmacist. Pharmacists’ involvement in programs such as the Medication Therapy Management, for example, can have a positive impact on health management in general.
“Pharmacy just keeps changing the name of what we do. Sometimes it's pharmaceutical care, sometimes it's drug regimen reviews, sometimes it’s drug utilization review, sometimes it’s counter detailing,” Haydon-Greatting says of the various functions a pharmacist performs.
“In the primary care providers, the nurse practitioners may only get them in for 3 to 4 times a year, if we're lucky. Because of that frequency and because they come to the stores to buy all their other over-the-counter medical products and so forth, we do have an opportunity to create access, a greater access,” she notes.
Pharmacists today are the bridges that can connect a patient and physician in the gap between visits, and prove to be an easily accessible and knowledgeable source of help and guidance.
Expert Insights on How Utilization Management Drives Physician Burnout
November 26th 2024On this episode of Managed Care Cast, we speak with the author of a study published in the November 2024 issue of The American Journal of Managed Care® to explore the link between utilization management and physician burnout.
Listen
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More